Related Experiment Video

Updated: May 19, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s)

Tilman B Drüeke1, Patrick S Parfrey

  • 1Inserm Unit 1088, UFR de Médecine et de Pharmacie, Université de Picardie Jules Verne, Amiens, France. tilman.drueke@inserm.fr

Kidney International
|August 3, 2012
PubMed

Insights

This guideline helps healthcare providers manage anemia in chronic kidney disease (CKD) patients. It focuses on practical aspects to improve patient care and inform clinical decisions.

Area of Science:

  • Nephrology
  • Internal Medicine

Background:

  • Anemia is a common complication in chronic kidney disease (CKD).
  • Effective management of anemia in CKD is crucial for patient outcomes.
  • The Kidney Disease: Improving Global Outcomes (KDIGO) provides clinical practice guidelines.

Purpose of the Study:

  • To present practical clinical aspects of the KDIGO anemia guideline for CKD.
  • To assist healthcare providers in treating anemia in CKD patients.
  • To facilitate informed clinical decision-making based on evidence and expert judgment.

Main Methods:

  • The study focuses on summarizing and applying the KDIGO clinical practice guideline.
  • Emphasis is placed on practical, actionable recommendations for clinicians.
  • The guideline is intended for use by healthcare professionals in managing CKD anemia.

Main Results:

  • The KDIGO guideline offers evidence-based recommendations for anemia management in CKD.
  • It emphasizes individualized patient care and informed clinical judgment.
  • The guideline aims to improve the quality of care for CKD patients with anemia.

Conclusions:

  • The KDIGO guideline provides a framework for managing anemia in CKD.
  • Healthcare providers should utilize the guideline to make informed treatment decisions.
  • Focusing on practical aspects enhances the applicability of the guideline for improved patient outcomes.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Guidelines For Measuring Vital Signs01:19

Guidelines For Measuring Vital Signs

Following these guidelines can help nurses accurately measure vital signs, assess changes in patient conditions, and provide timely treatment when necessary. Adhering closely to the guidelines ensures the accuracy and reliability of the results.
Before taking a patient's vital signs, a nurse would consider and assess the patient's comfort level and ensure appropriate equipment is available.
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...